Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

458 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir

NCT01046799

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +10 more
Locations: University Clinic Essen Essen, Germany

Hannover Medical School Hanover, Germany

University Hospital Heidelberg Heidelberg, Germany

View Trial Details

Completed

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

NCT00315055

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +34 more
Locations: Ankara, Turkey (Türkiye)

View Trial Details

Completed

Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients

NCT02108444

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +17 more
Locations: Peking University Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

NCT01444781

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +32 more
Locations: Cali, Colombia

San José, Costa Rica

View Trial Details

Completed

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

NCT01917357

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations: Research Institute for Tropical Medicine City of Muntinlupa, Philippines

View Trial Details

Completed

Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

NCT02152709

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Jiangsu Provincial Center for Disease Control and Prevention Nanjing, Jiangsu, China

View Trial Details

Completed

Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants

NCT00404651

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +33 more
Locations: Estado de México, Mexico

Estado de México, Mexico

Insurgentes Cuicuilco, Mexico

Monterrey, Mexico

View Trial Details

Completed

A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants

NCT01177722

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +32 more
Locations: Cali, Colombia

San José, Costa Rica

View Trial Details

Completed

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

NCT00362336

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +35 more
Locations: Soweto, Johannesburg, South Africa

Bertsham, South Africa

View Trial Details

Completed

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

NCT00313911

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Mexico City, Mexico

Lima, Peru

View Trial Details

Hepatitis B

Hepatitis B trial results

Related conditions